Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=52012059&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20150040(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2008/070088external-prioritypatent/WO2009012268A1/en
Application filed by Genentech IncfiledCriticalGenentech Inc
Publication of CR20150040ApublicationCriticalpatent/CR20150040A/en
La presente invención se centra en composiciones de sustancias útiles para el tratamiento de tumores hematopoyéticos en mamíferos, así como los métodos para usar dichas composiciones de sustancias con el mismo objetivo.The present invention focuses on compositions of substances useful for the treatment of hematopoietic tumors in mammals, as well as methods for using said compositions of substances for the same purpose.
CR20150040A2007-07-162015-01-29
ANTI-CD79B ANTIBODIES AND IMMUNOCATE PLAYERS
CR20150040A
(en)
Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors.